Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated at StockNews.com
Analysts at StockNews.com assumed coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Get Free Report) in a research report issued on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price objective on Minerva Neurosciences from $11.00 to $7.00 and set a “neutral” rating on the stock […]
More Stories
Centessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Gregory M. Weinhoff Sells 10,000 Shares
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) insider Gregory M. Weinhoff sold 10,000 shares of the firm’s stock in...
Analysts Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Price Target at $166.00
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the...
Applied Materials, Inc. (NASDAQ:AMAT) Given Average Recommendation of “Moderate Buy” by Analysts
Applied Materials, Inc. (NASDAQ:AMAT – Get Free Report) has been given an average rating of “Moderate Buy” by the twenty-two...
Quest Resource Holding Co. (NASDAQ:QRHC) Director Glenn Culpepper Buys 2,000 Shares
Quest Resource Holding Co. (NASDAQ:QRHC – Get Free Report) Director Glenn Culpepper bought 2,000 shares of the company’s stock in...
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) Insider Sells 33,402 Shares of Stock
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Mark Andrew Wilson sold 33,402 shares of the company’s stock in a...
Insider Selling: Impinj, Inc. (NASDAQ:PI) COO Sells 826 Shares of Stock
Impinj, Inc. (NASDAQ:PI – Get Free Report) COO Hussein Mecklai sold 826 shares of Impinj stock in a transaction on...